Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 12, 2016, Pages 3556-3561

  Otter, Jonathan A ^a   Dyakova, Eleonora ^a   Bisnauthsing, Karen N ^a   Querol Rubiera, Antonio ^a   Patel, Amita ^a   Ahanonu, Chioma ^a   Auguet, Olga Tosas ^a   Edgeworth, Jonathan D ^a   Goldenberg, Simon D ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CARBAPENEMASE; CEFOTAXIME; ERTAPENEM; VANCOMYCIN; BACTERIAL PROTEIN; BETA LACTAMASE;

ADULT; ARTICLE; BACTERIUM CULTURE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA COLI; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NONHUMAN; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; RISK FACTOR; SCREENING; DIAGNOSTIC TEST; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; FEMALE; GENOTYPING TECHNIQUE; HETEROZYGOTE; HOSPITAL; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PREVALENCE; PROCEDURES; QUESTIONNAIRE; RECTUM; STANDARDS; UNITED KINGDOM; UTILIZATION;

ADULT; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CARRIER STATE; DIAGNOSTIC TESTS, ROUTINE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GENOTYPING TECHNIQUES; HOSPITALS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; RECTUM; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM;

EID: 85012010942     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/JAC/DKW309     Document Type: Article

References (28)

1. Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-8
2. Karah N, Sundsfjord A, Towner K et al. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 2012; 15: 237-47
3. Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 2014; 58: 697-703
4. Jain A, Hopkins KL, Turton J et al. NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. J Antimicrob Chemother 2014; 69: 1777-84
5. Walsh TR, Weeks J, Livermore DM et al. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11: 355-62
6. Hughes J, Goldenberg SD, Tosas Auguet O et al. Recent emergence of carbapenem-resistant organisms in a low prevalence UK setting in London. J Infect Prevent 2016; 17: 130-4
7. Drew RJ, Turton JF, Hill RL et al. Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital. J Hosp Infect 2013; 84: 300-4
8. PHE. Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. 2013. https://www. gov.uk/government/uploads/system/uploads/attachment_data/file/329227/Acute_trust_toolkit_for_the_early_detection.pdf
9. Lewis T, Loman NJ, Bingle L et al. High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J Hosp Infect 2010; 75: 37-41
10. Turton JF, Kaufmann ME, Gill MJ et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol 2006; 44: 2630-4
11. Tacconelli E, Cataldo MA, Dancer SJ et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20 Suppl 1: 1-55
12. Otter JA, Mutters NT, Tacconelli E et al. Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries. Clin Microbiol Infect 2015; 21: 1057-66
13. Birgand G, Armand-Lefevre L, Lepainteur M et al. Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country. Clin Microbiol Infect 2014; 20: O887-90
14. Girlich D, Bouihat N, Poirel L et al. High rate of faecal carriage of extended-spectrum b-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco. Clin Microbiol Infect 2014; 20: 350-4
15. Mack D, Scott J, Pang V et al. One year's experience of carbapenemase screening at a London Teaching Hospital. HIS Conference. 2014
16. Venanzio V, Gharbi M, Moore LS et al. Screening suspected cases for carbapenemase-producing Enterobacteriaceae, inclusion criteria and demand. J Hosp Infect 2015; 71: 493-5
17. Viau R, Frank KM, Jacobs MR et al. Intestinal carriage of carbapenemase-producing organisms: current status of surveillance methods. Clin Microbiol Rev 2016; 29: 1-27
18. Willems E, Cartuyvels R, Magerman K et al. Evaluation of 3 different agar media for rapid detection of extended-spectrum b-lactamase-producing Enterobacteriaceae from surveillance samples. Diag Microbiol Infect Dis 2013; 76: 16-9
19. Lau AF, Fahle GA, Kemp MA et al. Clinical performance of Check-Direct CPE, a multiplex PCR for direct detection of blaKPC, blaNDM/VIM, and blaOXA48 from Perirectal Swabs. J Clin Microbiol 2015; 53: 3729-37
20. Huang TD, Bogaerts P, Ghilani E et al. Multicentre evaluation of the Check-Direct CPE(R) assay for direct screening of carbapenemaseproducing Enterobacteriaceae from rectal swabs. J Clin MIcrobiol 2015; 70: 1669-73
21. Van Horn KG, Audette CD, Tucker KA et al. Comparison of 3 swab transport systems for direct release and recovery of aerobic and anaerobic bacteria. Diag Microbiol Infect Dis 2008; 62: 471-3
22. Smismans A, Verhaegen J, Schuermans A et al. Evaluation of the Copan ESwab transport system for the detection of methicillin-resistant Staphylococcus aureus: a laboratory and clinical study. Diag Microbiol Infect Dis 2009; 65: 108-11
23. KimJ, LeeJY, KimSI et al. Ratesof fecal transmission of extended-spectrum b-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea. Ann Lab Med 2014; 34: 20-5
24. Swaminathan M, Sharma S, Poliansky Blash S et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 2013; 34: 809-17
25. Day KM, Ali S, Mirza IA et al. Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. Diag Microbiol Infect Dis 2013; 75: 187-91
26. Lin MY, Lyles-Banks RD, Lolans K et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2013; 57: 1246-52
27. Findlay J, Hopkins KL, Meunier D et al. Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteria. J Antimicrob Chemother 2015; 70: 1338-42
28. Nijhuis R, Samuelsen O, Savelkoul P et al. Evaluation of a new real-time PCR assay (Check-Direct CPE) for rapid detection of KPC, OXA-48, VIM, and NDM carbapenemases using spiked rectal swabs. Diag Microbiol Infect Dis 2013; 77: 316-20